1440 Obrien Drive
3 articles with Octave
Octave, an innovator in outcomes-focused behavioral health, announced that it has raised $20 million in Series B funding, bringing its total raised to $34 million.
Octave Bioscience to Present New Analyses Addressing the Complex Unmet Needs of Multiple Sclerosis Through Quantitative and Image-Based Measurement of Multiple Pathways and Their Biomarkers at the ACTRIMS Forum 2021
Octave Bioscience (Octave), the developer of a fully integrated care management platform for multiple sclerosis (MS) and other neurodegenerative diseases, today announced the presentation of five posters at the ACTRIMS Forum 2021.
Northpond Ventures leads round New investors include Deerfield Management and Casdin Capital. All existing investors participated including The Blue Venture Fund, Echo Health Ventures and Section 32 Funds will be used to complete development of Octave Bioscience’s Comprehensive Care Platform and initiate early commercial activities